AR060049A1 - MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME - Google Patents
MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAMEInfo
- Publication number
- AR060049A1 AR060049A1 ARP070101165A ARP070101165A AR060049A1 AR 060049 A1 AR060049 A1 AR 060049A1 AR P070101165 A ARP070101165 A AR P070101165A AR P070101165 A ARP070101165 A AR P070101165A AR 060049 A1 AR060049 A1 AR 060049A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- halogen
- alkoxy
- group
- substituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 16
- 150000002367 halogens Chemical group 0.000 abstract 16
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 11
- 125000003545 alkoxy group Chemical group 0.000 abstract 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000004414 alkyl thio group Chemical group 0.000 abstract 5
- 229910052799 carbon Inorganic materials 0.000 abstract 5
- 229910052760 oxygen Inorganic materials 0.000 abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 4
- 125000001072 heteroaryl group Chemical group 0.000 abstract 4
- 229910052717 sulfur Inorganic materials 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- -1 1H-tetrazol-5-yl Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000001769 aryl amino group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000005241 heteroarylamino group Chemical group 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicacion 1: Un compuesto caracterizado porque responde a la formula (1) en donde A es un grupo arilo o heteroarilo opcionalmente sustituido; B y C son un sistema de anillos bicíclico al menos parcialmente aromático; X se selecciona en el grupo que consiste de WC(O)OR6a, WP(O)R6bR6c, WS(O)2OH, WCONHSO3H o 1H-tetrazol-5-ilo; cuando W es un enlace directo, oxígeno o alquilo C1-4 con uno o más sustituyentes seleccionados en forma independiente entre el grupo que consiste de grupos halogeno, hidroxilo, ciano, amino, alquilamino, arilamino, heteroarilamino, alcoxi C1-4 y COO2H; R6a es hidrogeno o alquilo C1-4; y R6b y R6c son en forma independiente hidrogeno, hidroxilo, alquilo C1-4 o alquilo C1-4 sustituido con halogeno; Y es un residuo de formula (2) donde los asteriscos izquierdo y derecho indican el punto de union, en donde Q se selecciona entre el grupo que consiste de enlace directo, C=O, C=S, SO2, C=ONR o (CR10R11)m; m es 0, 1, 2 o 3; R7 y R8 se seleccionan en forma independiente entre el grupo que consiste de hidrogeno, halogeno, amino, alquil C1-5amino, hidroxilo, ciano, alquilo C1-6, hidroxialquilo C1-6 (por ejemplo, alquilo terminado con hidroxi), alquiltio C1-5, alcoxi C1-5, alquilo C1-6 sustituido con halogeno y alcoxi C1-5 sustituido con halogeno; o R7 y R8 pueden unirse con los átomos a los cuales están unidos para formar un anillo de 4 a 7 miembros, que tiene opcionalmente un heteroátomo; y R9 se selecciona entre el grupo que consiste de hidrogeno, halogeno, hidroxilo, ciano, alquilo C1-6, alquiltio C1-5, alcoxi C1-5, alquilo C1-6 sustituido con halogeno o alcoxi C1-5 sustituido con halogeno; R10 y R11 se seleccionan en forma independiente entre el grupo que consiste de hidrogeno, halogeno, hidroxilo, ciano, alquilo C1-6, alcoxi C1-5, alquiltio C1-5, alquilo C1-6 sustituido con halogeno o alcoxi C1-5 sustituido con halogeno; y Z1 y Z2 se seleccionan en forma independiente entre el grupo que consiste de O, NR3, S, S(O), S(O)2, S(O)2NR3, (CR4R5)n, C=O, C=S, C=N-R3, o un enlace directo, donde R3 se selecciona entre el grupo que consiste de hidrogeno, hidroxilo, SO2, C=O, C=S, C=NH, alquilo C1-6, alcoxi C1-5, alquiltio C1-5, alquilo C1-6 sustituido con halogeno y alcoxi C1-5 sustituido con halogeno; arilo o heteroarilo, o cuando Z2 es un enlace directo, R3 es un anillo de C3-6 que contiene opcionalmente un heteroátomo; R4 y R5 se seleccionan en forma independiente entre el grupo que consiste de hidrogeno, halogeno, hidroxilo, ciano, alquilo C1-6, alcoxi C1-5, alquiltio C1-5, alquilo C1-6 sustituido con halogeno y alcoxi C1-5 sustituido con halogeno; arilo o heteroarilo o formar juntos C=O; y n es 0, 1, 2 o 3; y R1 se selecciona entre el grupo que consiste de alquilo C1-6, alquenilo C2-6, alquinilo C2-6, cicloalquilo C3-6, alcoxi C1-5, alquil C1-5amino, arilo o heteroarilo.Claim 1: A compound characterized in that it responds to formula (1) wherein A is an optionally substituted aryl or heteroaryl group; B and C are an at least partially aromatic bicyclic ring system; X is selected from the group consisting of WC (O) OR6a, WP (O) R6bR6c, WS (O) 2OH, WCONHSO3H or 1H-tetrazol-5-yl; when W is a direct bond, oxygen or C1-4 alkyl with one or more substituents independently selected from the group consisting of halogen, hydroxyl, cyano, amino, alkylamino, arylamino, heteroarylamino, C1-4 alkoxy and COO2H groups; R6a is hydrogen or C1-4 alkyl; and R6b and R6c are independently hydrogen, hydroxyl, C1-4 alkyl or C1-4 alkyl substituted with halogen; Y is a residue of formula (2) where the left and right asterisks indicate the junction point, where Q is selected from the group consisting of direct bond, C = O, C = S, SO2, C = ONR or ( CR10R11) m; m is 0, 1, 2 or 3; R7 and R8 are independently selected from the group consisting of hydrogen, halogen, amino, C1-5 alkyl, hydroxy, cyano, C1-6 alkyl, hydroxy C1-6 alkyl (eg, hydroxy terminated alkyl), C1 alkylthio -5, C1-5 alkoxy, C1-6 alkyl substituted with halogen and C1-5 alkoxy substituted with halogen; or R7 and R8 can bind to the atoms to which they are attached to form a 4- to 7-membered ring, which optionally has a heteroatom; and R9 is selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, C1-6 alkyl, C1-5 alkylthio, C1-5 alkoxy, halogen substituted C1-6 alkyl or halogen substituted C1-5 alkoxy; R10 and R11 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, C1-6 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-6 alkyl substituted with halogen or C1-5 alkoxy substituted with halogen; and Z1 and Z2 are independently selected from the group consisting of O, NR3, S, S (O), S (O) 2, S (O) 2NR3, (CR4R5) n, C = O, C = S , C = N-R3, or a direct bond, where R3 is selected from the group consisting of hydrogen, hydroxyl, SO2, C = O, C = S, C = NH, C1-6 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-6 alkyl substituted by halogen and C1-5 alkoxy substituted by halogen; aryl or heteroaryl, or when Z2 is a direct bond, R3 is a C3-6 ring optionally containing a heteroatom; R4 and R5 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, cyano, C1-6 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-6 alkyl substituted with halogen and C1-5 alkoxy substituted with halogen; aryl or heteroaryl or together form C = O; and n is 0, 1, 2 or 3; and R1 is selected from the group consisting of C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, C1-5 alkoxy, C1-5amino alkyl, aryl or heteroaryl.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78454906P | 2006-03-21 | 2006-03-21 | |
| US11/491,766 US7855193B2 (en) | 2005-11-23 | 2006-07-24 | S1P receptor modulating compounds and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR060049A1 true AR060049A1 (en) | 2008-05-21 |
Family
ID=39456287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070101165A AR060049A1 (en) | 2006-03-21 | 2007-03-21 | MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR060049A1 (en) |
| PE (1) | PE20080248A1 (en) |
-
2007
- 2007-03-21 AR ARP070101165A patent/AR060049A1/en unknown
- 2007-04-25 PE PE2007000512A patent/PE20080248A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20080248A1 (en) | 2008-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR060050A1 (en) | MODULATING COMPOUNDS OF THE S1P RECEIVER AND USE OF THE SAME | |
| PE20121282A1 (en) | SPIRO-OXINDOL ANTAGONISTS OF MDM2 | |
| CO6231035A2 (en) | NOVEDOUS HETEROMONOCICLIC COMPOUND THAT HAS SUPERIOR PROPERTIES AS A PHARMACEUTICAL AGENT | |
| NZ777370A (en) | Bicyclic derivatives | |
| ES2452299T3 (en) | Heterocyclic Fungicidal Compounds | |
| AR057987A1 (en) | CB1 AGONIST COMPOUNDS (CANNABINOID RECEPTOR) | |
| AR049388A1 (en) | HETEROCICLES AS INHIBITORS OF ALDOSTERONA SINTASA | |
| CO6220949A2 (en) | PIRAZOLIC DERIVATIVES AS INHIBITORS OF THE 11 BETA -HSD1 | |
| BRPI0922366B8 (en) | compound, pharmaceutical composition and use of a compound | |
| MX2021007540A (en) | Bicyclic derivatives. | |
| AR076810A1 (en) | ANTI-BANERIGEN COMPOUNDS OF AMINO PYRIMIDINE | |
| BR112017021803A2 (en) | bicyclic quinazolinone derivatives | |
| HN2008000179A (en) | TRICYCLE COMPOUNDS, COMPOSITIONS AND PROCEDURES | |
| MX2015010775A (en) | Substituted benzoxazoles and methods of use thereof. | |
| MX2015014861A (en) | C-linked heterocycloalkyl substituted pyrimidines and their uses. | |
| CY1111628T1 (en) | Substituted bicyclactam compounds | |
| MX392211B (en) | 5-FLUORO-4-IMINO-3-(ALKYL/SUBSTITUTED ALKYL)-1-(ARYLSULFONYL)-3,4-DIHYDROPYRIMIDIN-2(1<i>H</i>)-ONE AND PROCESSES FOR THEIR PREPARATION | |
| AR061923A1 (en) | COMPOUNDS DERIVED FROM BENZOFURAN-PIPERIDINA | |
| AR074435A1 (en) | DERIVATIVES OF 1,3-BENZOTIAZOL, DRUGS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF CANCER. | |
| AR088449A1 (en) | BENZILINDAZOLES REPLACED | |
| AR058404A1 (en) | DIAMINE DERIVATIVES AS INHIBITORS OF LEUCOTRENE A4 HIDROLASA | |
| EA201071234A1 (en) | IZOHINOLINON DERIVATIVES AS NK3 ANTAGONISTS | |
| TW200732295A (en) | Selective N-sulfonylation of 2-amino trifluoroalkyl substituted alcohols | |
| ES2528441T3 (en) | Hetarylaminonaphthyridines | |
| AR078270A1 (en) | JAK INHIBITORS (JANUS QUINASAS) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |